The Democratic West Virginia senator's daughter, Heather Bresch, is CEO of Mylan, the manufacturer of EpiPens.
It was not an especially convincing performance.
"Thus we are basically rolling back the increase of the past year", he said.
Editor's note: Updated at 9:20 am ET to include Mylan's announcement that it will reimburse consumers for some of their out-of-pocket costs.
But the drugmaker didn't budge on its price hikes Thursday, which have drawn ire both in Congress and from families that have had to shell out increasingly large sums for the potentially life-saving treatment. "Nobody is buying this PR move any more".
Drug companies generally use savings cards because they foster good relationships with patients by defraying the out-of-pocket costs for medication.
"We've put hundreds of millions of dollars behind it", Bresch said.
And now about that CNBC spot.
An EpiPen is an injector that contains about $1 worth of epinephrine. This is what you get when third-parties pay for everything.
The price for these devices has skyrocketed 400% recently, and yet ABC and CBS, in talking about this, have failed to identify the pharmaceutical company involved.
She paid $175 under an old insurance plan but now has a high-deductible plan and she's already exhausted her health savings account.
Interviewer Brian Kelly pointed out that Bresch apparently used her power as a lobbyist-turned-CEO and her influence with heads of state to legislate a market for her company's product, then inflated the price.
"Others don't have a job like me and can't afford it", he said. That the American Medical Association has said this is basically the same product it was in 2009.
"No one's more frustrated than me", she said. I've been in this business for 25 years...
"Can you use an expired one?"
According to Bresch, "there are four or five hands that the product touches and companies that it goes through before it ever gets to that patient at the counter". I'm hoping that this is an inflection point for this country. This bubble is going to burst. Senators including Amy Klobuchar (D-MN), Chuck Grassley (R-IA), Bernie Sanders (I-VT), and Richard Blumenthal (D-CT) have either called for an investigation, demanded Mylan lower the price or requested new info.
In some ways, what is playing out with EpiPen is simply a repeat of other drug price hikes that have garnered attention and outrage - and eventually quieted down. But make no mistake, Mylan has cashed in. That would cut the bill in half for patients who have to pay full price. "Who is that? It wasn't passed on to customers".
But Mylan's stock, which had fallen over 10 per cent this week, rose 3.2 per cent today, after announcement of its discount programme. That's still almost three times the list price when it acquired the product. But that doesn't excuse her company's own role.
The Wall Street Journal detailed extensively as Clinton threw herself into the conflict that the Food and Drug Administration (FDA) has made it very hard for competitors to enter the marketplace and push prices downward.
And while Parker's voice brings to the forefront the most important issues about the Mylan controversy, she's right that it's up to the company to make the change. "The fault here lies in the insurance companies".
Q: Has the price increased in Canada?
"Answer the question-you answer to shareholders", Shkreli tweeted.